White label – Pompe disease - ClinicalTrials.eu

Study of REGN7257 for Adults with Severe Aplastic Anemia Unresponsive to or Relapsed After Immunosuppressive Therapy

Not recruiting

2 1 1
Investigated Diseases:
- Aplastic anaemia
Investigated Drugs:
- Regn7257
Study of Pirtobrutinib for Patients with Previously Treated Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, or Non-Hodgkin Lymphoma

Not recruiting

2 1 1
Investigated Drugs:
- Pirtobrutinib
Study on Pritelivir for Treating Acyclovir-Resistant Herpes Simplex Virus in Immunocompromised Patients

Not recruiting

3 1 1 1
Investigated Diseases:
- Herpes simplex
Investigated Drugs:
Study on the Effects of EVX-01 and Pembrolizumab in Adults with Advanced Melanoma

Not recruiting

2 1 1 1
Investigated Diseases:
- Metastatic malignant melanoma
Investigated Drugs:
- Evx-01
- Pembrolizumab
Study on Long-Term Safety of Secukinumab for Patients with Polymyalgia Rheumatica

Not recruiting

3 1 1 1
Investigated Drugs:
- Secukinumab
+4
Study on the Safety and Effectiveness of BI 3720931 for Adults with Cystic Fibrosis Who Cannot Use CFTR Modulators

Not recruiting

2 1 1
Investigated Diseases:
- Cystic fibrosis lung
Investigated Drugs:
- Bi 3720931
- Gadobutrol
Study of Letetresgene Autoleucel for Patients with Synovial Sarcoma and Myxoid/Round Cell Liposarcoma

Not recruiting

2 1 1
Investigated Diseases:
Investigated Drugs:
- Letetresgene Autoleucel
Long-Term Study of Tofacitinib for Children and Teens with Juvenile Idiopathic Arthritis

Not recruiting

4 1 1 1
Investigated Diseases:
- Juvenile idiopathic arthritis
Investigated Drugs:
- Tofacitinib Citrate
- Tofacitinib
Long-Term Safety Study of BI 3720931 for Patients with Cystic Fibrosis from a Previous Trial

Not recruiting

1 1 1
Investigated Drugs:
- Bi 3720931
Study on the Safety and Effects of Afamelanotide for Patients with Early Parkinson’s Disease

Not recruiting

2 1 1
Investigated Diseases:
- Parkinson’s disease
Investigated Drugs:
- Afamelanotide

Full Name *

e-Mail *

Country Prefix *

Phone Number *

Nationality *

Gender *

Check all consents

Check all consents

I accept the Terms and Conditions and Privacy Policy *

*I accept the Terms and Conditions and Privacy Policy

I consent to receiving commercial information from the Service Operator *

*I consent to receiving commercial information from the Service Operator

I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes *

*I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes

We use cookies